
13 Feb 2025
Consumables business divestment concludes
Creo Medical has completed the sale of the majority (51%) stake in its European consumable business to Chinese medical device manufacturer Micro-Tech for net proceeds of c €30m (c £25m). The deal valued the mature European business at €72m on an EV/sales multiple of 2.3x and an EV/EBIT multiple of

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Consumables business divestment concludes
Creo Medical Group Plc (CREO:LON) | 12.9 0 0.6% | Mkt Cap: 53.1m
- Published:
13 Feb 2025 -
Author:
Jyoti Prakash, CFA | Arron Aatkar, PhD -
Pages:
2 -
Creo Medical has completed the sale of the majority (51%) stake in its European consumable business to Chinese medical device manufacturer Micro-Tech for net proceeds of c €30m (c £25m). The deal valued the mature European business at €72m on an EV/sales multiple of 2.3x and an EV/EBIT multiple of